Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07509879

Research on the Molecular Mechanism of Cognitive Differences Between Williams Syndrome and Autism Spectrum Disorder

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
75 (estimated)
Sponsor
Qilu Hospital of Shandong University · Academic / Other
Sex
All
Age
3 Years – 12 Years
Healthy volunteers
Accepted

Summary

Williams Syndrome (WS) is a rare neurodevelopmental disorder, usually caused by microdeletions of approximately 26 genes in the long arm (7q11.23) region of chromosome 7. Children with this syndrome often exhibit distinctive facial features, mild to moderate intellectual disability, impaired spatial cognition, pronounced social extraversion, and relatively reserved language-expression characteristics. Although individuals with WS often demonstrate strong social interest and prosocial behaviors, significant deficiencies in abstract thinking, executive function, and visuospatial ability are frequently observed. At present, treatment for WS mainly focuses on behavioral intervention and educational rehabilitation, and clear molecular or pharmacological treatment methods remain limited. Due to the "opposite but related" social-cognitive profile observed in comparison with autism spectrum disorder, in-depth exploration of neural and molecular mechanisms underlying these differences has substantial scientific significance for understanding the biological basis of social-cognitive impairment.

Conditions

Timeline

Start date
2026-04-01
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2026-04-03
Last updated
2026-04-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07509879. Inclusion in this directory is not an endorsement.